Premier Veterinary Share Discussion Threads

[netcurtains] 03/6/2016 20:07

I'm still here. Not in profit yet... Oh well. But does sound good.

[pet lover] 03/6/2016 19:40

The Daily Mail June 03 2016.
Pet Project.
Premier Veterinary Group saw its shares spike yesterday after signing a deal in the US. The company agreed a fiver year tie up with Veterinary Products to supply its preventative healthcare scheme,which is expected to reach 200,000 pets across 15 states over the period. Shares rose 7.3% or 10P to £1.47.

[pet lover] 02/6/2016 19:11

Today's contract win is far and above my expectations in such a short period since PVG launched in America.
The hound and I were thinking along the lines of 60 vets so over 600 is a bit of a shock.PVG are not hanging around and if they can sell the planned 40,000 a year we will be 😄.
At a stroke it now looks as if my sales target for 2016/2017 of at least 150,000 plans sold is now achievable giving a total of 300,000 by September 2017. All the building blocks are falling into place for rapid 100% year on year sales growth. Not sure if a shareholder could ask for much more than that.It is the recurring revenues that are such a draw over the long term. Each plan sold is banked for future years less a few percent that fall by the wayside. It's the quality of those earnings that gets very highly valued on both sides of the Atlantic. I still have yet to see any broker research or forecast on Digital Look or Hargreaves and don't see the shares doing much until their is as PVG only has the half a dozen followers on this BB as far as I can see.

[pet lover] 02/6/2016 18:29

Home after a long hot day to read this mornings news. RNS Number : 9654Z

Premier Veterinary Group PLC

02 June 2016

PREMIER VETERINARY GROUP PLC

("PVG" or "the Company")

MAJOR AGREEMENT SIGNED IN THE US FOR PREMIER PET CARE PLAN

London, UK, 2 June 2016 - Premier Veterinary Group plc (LSE: PVG) announces that its wholly-owned subsidiary, Premier Vet Alliance (US) Limited ("PVA"), has signed a major agreement with Veterinary Products, Inc. ("VPI"), a significant veterinary distributor co-op, headquartered in Atlanta, Georgia, US.

The contract is to supply the Company's preventative healthcare program for pets, branded in the US as "Premier Pet Care Plan" ("PPCP"), to VPI's member hospitals numbering over 600 across 15 States, located primarily in the South East of the US.

The initial 5-year agreement is to introduce PPCP to VPI's member hospitals and the target over the contract period is to reach at least 200,000 pets on plan. The first pets on plan are expected during the second half of the calendar year.

Bob MacDonald, President of VPI, commented:

"VPI has run wellness programs in the past, but PVA is the first to come to us with a model that delivers a product-led program with a comprehensive support package and delivering an end-to-end solution. We are a veterinarian and product driven distributor with very efficient delivery systems, and PVA meets our exacting requirements on customer service."

Dominic Tonner, Chief Executive Officer of PVG, added:

"We are delighted to have secured such a prestigious contract so soon after announcing our entry into the US market last month with our first 10 signed hospital contracts. VPI is an award winning business and a highly respected industry player. We look forward to a rapid and successful roll-out of our Premier Pet Care Plan across the VPI membership."

[smart_investor] 02/6/2016 07:51

Well done all PVG holders. Smashing RNS!

[hydrus] 02/6/2016 07:37

That will more than double the size of the current business over the next five years. They've only just started in the US so one might expect more such deals in due course. Huge opportunity here.

[hibberts] 02/6/2016 07:29

Yes, this looks exciting.

[bigglesbingham] 02/6/2016 07:21

Now that's what I call an rns!!!

[pet lover] 22/5/2016 10:11

Been to 🙏 Walked the hound and it's still not raining. Yet.
We have been evaluating the US as a target market for PCP for almost 2 years and feel the time is now right for our entry. We are now pleased to be able to announce our first steps in the south east region of the country. We plan a methodical build-up of our presence with the appointment of additional sales and training personnel to support the product within hospitals.
The hound and myself are both excited about these plans being sold in North America. Methodical build up being led by two high flyers is extremely tanterlising for investors.To hazard a guess how many new hospitals might these two sign up by September.To do this I thought how many visits could be made each week in person. I would aim for 2 each day plus phone calls. I would also target chains of hospitals be it small 1-5 or larger ones 10-30. Since both of the new sales directors have been in the game for years one might hope some doors would be wide open from the launch.Not sure it's even a hard sell its about the pet getting better care the pet owner getting peace of mind and the Hospital having a steady cash flow and higher turnover for all or most of its products and services. If each director picks up 5 a week I would be delighted tbh if the managed to get five a week in total it would be great.The breakthrough would come in the form of a large chain comming under contract in a few months time after the US directors have bedded in.
Plans are now being sold all over the place.
Time for a shower.

[pet lover] 19/5/2016 20:47

PVG are growing sales at 4% a month the hound and I like that.😯.This is what 4% compound sales growth equates to over five short years.

Month : VNew plans: Month on month : Total plans sold 117,000, (0N 01/04/16)
1 April 16 4,766.76 4,766.76 121,766.76
2 4,960.97 9,727.73 126,727.73
3 5,163.08 14,890.81 131,890.81
4 5,373.44 20,264.24 137,264.24
5 5,592.36 25,856.60 142,856.60
6 5,820.20 31,676.80 148,676.80
7 6,057.32 37,734.12 154,734.12
8 6,304.11 44,038.23 161,038.23
9 6,560.95 50,599.17 167,599.17
10 6,828.25 57,427.42 174,427.42
11 7,106.44 64,533.87 181,533.87
12 7,395.97 71,929.84 188,929.84
13 April 17 7,697.29 79,627.13 196,627.13
14 8,010.89 87,638.02 204,638.02
15 8,337.27 95,975.29 212,975.29
16 8,676.94 104,652.23 221,652.23
17 9,030.45 113,682.69 230,682.69
18 9,398.37 123,081.05 240,081.05
19 9,781.27 132,862.33 249,862.33
20 10,179.78 143,042.10 260,042.10
21 10,594.52 153,636.62 270,636.62
22 11,026.15 164,662.77 281,662.77
23 11,475.38 176,138.15 293,138.15
24 11,942.90 188,081.05 305,081.05
25 April 18 12,429.47 200,510.52 317,510.52
26 12,935.87 213,446.39 330,446.39
27 13,462.90 226,909.29 343,909.29
28 14,011.40 240,920.68 357,920.68
29 14,582.24 255,502.92 372,502.92
30 15,176.34 270,679.27 387,679.27
31 15,794.65 286,473.92 403,473.92
32 16,438.15 302,912.07 419,912.07
33 17,107.87 320,019.93 437,019.93
34 17,804.87 337,824.80 454,824.80
35 18,530.26 356,355.07 473,355.07
36 19,285.22 375,640.28 492,640.28
37 April 19 20,070.93 395,711.21 512,711.21
38 20,888.65 416,599.85 533,599.85
39 21,739.68 438,339.53 555,339.53
40 22,625.39 460,964.92 577,964.92
41 23,547.18 484,512.11 601,512.11
42 24,506.53 509,018.64 626,018.64
43 25,504.97 534,523.60 651,523.60
44 26,544.08 561,067.68 678,067.68
45 27,625.52 588,693.20 705,693.20
46 28,751.03 617,444.23 734,444.23
47 29,922.39 647,366.62 764,366.62
48 31,141.48 678,508.10 795,508.10
49 April 2o 32,410.23 710,918.33 827,918.33
50 33,730.67 744,649.00 861,649.00
51 35,104.91 779,753.91 896,753.91
52 36,535.14 816,289.04 933,289.04
53 38,023.64 854,312.68 971,312.68
54 39,572.78 893,885.46 1,010,885.46
55 41,185.03 935,070.49 1,052,070.49
56 42,862.97 977,933.46 1,094,933.46
57 44,609.28 1,022,542.74 1,139,542.74
58 46,426.73 1,068,969.47 1,185,969.47
59 48,318.23 1,117,287.70 1,234,287.70
60 50,286.79 1,167,574.48 1,284,574.48

The obvious question is ; can that rate be maintained or even grow over such a time frame.? The starting point has to be total worldwide market. The market is very large and if PVG pick up just 1% in the developed world it would be many times the 1.3M required in five years time.
Competition is another factor but as the plans in most parts of the world are non existent and PVG''S plans are tried and tested in the UK I don't see that as a problem.
Pricing power or lack of it, again seems not to be an issue. Customers are key ( the vet and client) have to be top priority without them PVG has nothing.

[hydrus] 10/5/2016 14:13

With the volume over the last two days you may have a point

[ginger_ninja1] 10/5/2016 11:48

From a technical prospective the last weeks share price moves have been some what strange.The market bid 25,000 at £1.25P most of last week and a smaller 3,000 at £1.38P . A few shares were on offer at 148P. Yesterday, after results and light selling the price was slammed down even though buys far outnumbered sells. Some buying this morning has seen the bid/ offer prices move up. A cynic could be correct in thinking yesterday's action was the work of the market jobbers trying to get some stock at low prices.

[hydrus] 09/5/2016 14:29

Thanks - no doubt most people would have a glance and think the same which is why I suspect this will not generate much interest until next year when I believe they will start making profits. Of course if the US grows quickly or they secure a contract with a large chain of vets then that might change.

[homebrewruss] 09/5/2016 14:20

PVG mentioned in paul scotts report today:

Appears he's just taken the report on face value without knowledge of recent history.

[hydrus] 09/5/2016 08:39

A loss as expected during this period of investment. Headline figures and loss don't look good without a further dig.£1.1m loss which includes £600k cost for additional expansion overseas, £200k finance cost which won't reappear and a one off bonus for directors of about £200k for their very successful turnaround and sale of the vet business. I anticipate that the overseas expansion costs will start to drop a bit in the existing territories now and that trend will continue over the next year or two. Pet plans appear to be on track for about 150,000 at year end in September which is a great base to start the new year when we should start to see real growth and momentum in Scandinavia and USA. Next year will be a different picture with I suspect the first reported profit. The size of that depends simply on number of pet plans they manage to sell. The buying group is treading water which is not unexpected. It brings some cash in so not a bad thing m.

[pet lover] 08/5/2016 13:18

From the article

As we pointed out in October, this year has been one of rapid growth for Proactis (PHD). The spend control software firm said last month that earnings rocketed by 53% in the year to July after surging by 120% in 2013. FinnCap predicts the'll grow by 135% in the year to 2015.

Of all the stocks above the real winner 20P to over £1.40P is PHD a software company with recurring revenues. Those recurring revenues have been the key to its success measured by its stock price performance.It has averaged around 100% growth but that is now forecast to be just 13%.
The hound and I have been attracted to PVG because of its capability to expand at Helta Skelta Rates accompanied by recurring revenue and very little competition outside the UK. A great many companies will do well to get 0 - 7 % growth with retailers seeing just this week reporting slumps of 10% on the High St. To find any stock that has growth above 20% is going to be rare 50% even rarer. I personally don't see PVG"S growth falling under 20% for at least five years.Thats long enough to set the hound and I up for life. I say that tongue in cheek as we all know lots can and often does go wrong even with the best laid plans.

[pet lover] 08/5/2016 12:42

Rip off Britain the BBC said bright sunshine we've had rain and buckets of it. I found this yesterday. It's two years old but of great interest as it refers to the fastest growth shares on the secondary market at the time. PVG is not on that market, being fully listed but for growth purposes it's a great illustration. I invite you to read it.
The hound and I have come to these conclusions. If this is the best of the bunch then I don't think I would want to be invested in all the other AIM stocks. For long term growth I would rule out the brick-maker and the Gem stone miner both suffer from constant pricing pressure. When you remove them,growth from the other 3 doesn't look that appealing to me. I now refer back to PVG and it's possible growth rate of doubling sales from 80,000 to 160,000 this financial year then doing the same next and again in the following year. If PVG can be seen to be doing this and costs are kept under tight control I am convinced the shares will eventually get noticed by the wider market and respond accordingly. The recurring revenues should ensure growth continues be it at a slower rate for years to come.

companies
By Lee Wild | Fri, 21st November 2014 - 16:47
Share this
AIM's fastest growing companies
There are hundreds of companies on AIM. Some are tiny and lose lots of money; others like ASOS (ASC) are worth over £2 billion and make substantial profits. But the junior market is the home of the growth stock, and some businesses have been growing earnings at breakneck speed. After screening the entire small-cap sector, we've uncovered the fastest-growing companies and give our take on prospects.
Of course, it's no surprise to hear about growth on AIM. That's typically reflected in high price/earnings (P/E) ratios and very little by way of income generation (see table). Yet many of the top five growth companies we've identified appear not to be trading on vastly overinflated valuation multiples despite the potential growth on offer.

Clearly, there is always risk associated with this type of company. Growth assumptions are baked into valuations and any earnings-miss will certainly be punished. However, hard work done improving margins and repairing balance sheets after the financial crisis laid the foundation for a profits recovery, and improving economic conditions generate an obvious benefit.

True, 2014 has not been quite the cakewalk many experts had predicted. Europe, the UK's biggest trading partner, remains a basket case and growth elsewhere, especially in China, has been more pedestrian than anticipated. "Despite setbacks, an uneven global recovery continues," said the International Monetary Fund (IMF) recently. It's why the organisation has just revised down global growth forecasts to 3.3%.

Yet, while geopolitical risk remains, and stockmarkets look certain to remain volatile, economists predict 3.8% growth in 2015. Even the eurozone should improve. Highly accommodative monetary policy, including historically low interest rates, should underpin a recovery.

So, which of AIM's high-flyers stand to benefit from this improved prognosis and have, perhaps, been overlooked by growth-hungry investors?

Michelmersh Brick Holdings

Earnings fell at Michelmersh Brick (MBH) in 2013, but first-half results this year were better-than-expected and forced Cenkos Securities to upgrade forecasts. Higher brick prices mean adjusted earnings per share (EPS) are now tipped to rocket by 1,000% in 2014, up from 0.2p to 2.2p. That’s more than double the 2012 figure, too. Next year, it's back down to earth, although forecast growth of 25% is not to be sniffed at, and average forecast growth for the two years is a stunning 511%.

Company Ticker Price (p) Mkt Cap (£m) Est EPS growth (Year 1) Est EPS growth (Year 2) Est EPS growth (Year 3) Forward PE ratio % price change (3 months) % price change (1 year) Dividend yield (%)
Michelmersh Brick Holdings MBH 61 49 1,000 23 - 28 -6 13 -
Greenko GKO 149 149 217 56 - 22 -14 -3 -
Havelock Europa HVE 19 19 158 41 23 10 -17 2 -
Mytrah Energy MYT 73 73 141 69 39 12 -17 -10 -
Gemfields GEM 50 50 136 104 38 20 5 29 -
Source: S&P Capital IQ, Investec Securities, Numis, Cenkos, finnCap, Oriel, Westhouse
MBH's share price is underpinned by investment land valued at 26p per share. Strip that out and Michelmersh shares trade on just 16 times current-year forecast earnings, dropping to 13 in 2015. That's a discount to the Construction & Materials sector. Unfair, says Cenkos:

We would argue that MBH should trade at a premium to this operating in an industry impacted by a supply demand deficit with high barriers to entry preventing significant additions to supply capacity. There is scope for a sustained recovery underpinned by political pressure to resolve the UK housing shortage and the minor £3,000 cost of bricks for the average UK house is indicative that there is scope for sustained price increases.
Gemfields

Precious stones miner Gemfields (GEM) is the only company in the list of super-growth firms expected to double earnings for the next two years. Look for EPS growth of 136% in the year to June 2015, a further 104% surge in 2016, and 38% the following year, says Investec Securities.

At its recent auction in Lusaka, Zambia, the company auctioned 0.598 million carats of higher quality emeralds from its Kagem mine. That generated revenue of $34.9 million, the second highest achieved at higher quality auctions to date. An average value of $65.89 per carat is a record for Kagem stones.

And look out for another ruby auction next month. A maiden sale in August of stones from the Montepuez mine raised $15.5 million. That more than covered all investment in the asset, said Investec. We know Gemfields has ramped up production since, so there are high hopes. A strong dollar means the broker thinks the shares are worth 61.1p.

Havelock Europa

If Havelock Europa's crucial fourth quarter goes to plan, the interior designer will make a £0.9 million profit in 2014, up from £0.6 million the year before. Half-year results were certainly encouraging. Havelock typically loses money in the first half and broker Oriel Securities thinks it will generate almost two-thirds of sales during the final six months of the year.

In 2015, Oriel reckons Havelock could make £1.3 million. It's diversifying revenues and net debt is falling. Overseas sales are rising, too, and management expects an uptick in demand from the high street banks and retailers, student accommodation and the education sector. Clearly, the weak education market is worrying investors and the share price has fallen since September's results, but Oriel sticks with its 30p target price.

Greenko

Greenko (GKO) builds and runs clean energy projects in India, and it’s clearly big business. In a recent first-half update, the company increased power generation by 89% to 1,225 gigawatts (GWh), which, it said, should grow first-half revenue by over 120% cash profit by about 130%.

"As the Indian energy market becomes increasingly favourable towards hydro and wind power, we remain very optimistic about the sustainability of our solid operational and financial performance," said boss Anil Chalamalasetty.

Installed capacity increased by 136 megawatts (MW) to 697 MW, and Greenko says it’s still on track for its operational portfolio to exceed 1,000 MW in 2015. That’s why house broker Arden Partners has pencilled in adjusted EPS growth of 217% for the year to March 2015. The company has also refinanced its Standard Chartered debt on better terms following a $125 million investment from EIG Global Energy Partners. Says Arden:

The back-end loaded structure of the interest payments works well with renewable assets and further de-risks Greenko's finances following last month's bond issue. This and the likely upward pressure on electricity prices from the re-auctioning of coal mines puts Greenko in a strong position that has not been reflected in a relatively flat share price.
Mytrah Energy

Mytrah Energy (MYT), the India-based power company, has raised $70 million of new debt to cover an existing mezzanine facility and to develop new wind power projects currently in the pipeline. Half-year results published in September revealed a slow start to the wind season, although conditions have picked up and, according to Investec, full-year numbers are still achievable.

That keeps Mytrah on track to make a $19 million profit this year and $31 million in 2015. Of course, there are risks here, but "recent political and economic developments play to the advantage of the renewable producers," reckons Investec, which repeats its 165p target price.

One-year wonders

As we pointed out in October, this year has been one of rapid growth for Proactis (PHD). The spend control software firm said last month that earnings rocketed by 53% in the year to July after surging by 120% in 2013. FinnCap predicts the'll grow by 135% in the year to 2015.

Growth slows to a much more modest 8% the year after, but despite tripling already this year, finnCap reckons even its recently-raised target price of 115p may be conservative.

Christie (CTG) is expected to double adjusted pre-tax profit to £2.9 million and EPS to 8.38p in 2014, according to Charles Stanley. After that, it's more modest progress of 6% and 9% respectively.

Plus500 (PLUS) is slated to double profit to $138 million and grow EPS by 94% to 91 US cents, says Numis Securities. In 2015, that slows to 15%, then 13% the year after.

Brady (BRY) will ramp up adjusted pre-tax profit by 96% to £4.9 million, if Panmure Gordon has got its sums right. It’s 16% and 14% in subsequent years.

The finishing line is in sight for hostel operator Safestay (SSTY), spun out of Safeland in May. It's on track to grow EPS by 122% to 4.8p, although there's a pause next year before a resumption of double-digit growth in 2016.

Elsewhere, skin-focused pharma firm Sinclair IS Pharma (SPH) is tipped to grow earnings by 37% in the year to June 2015 and 53% the following year. That's impressive, and a forward PE ratio of less than 17 is an unfair discount to the sector. Directors certainly think so. They've just spent over £200,000 on shares in the company.

And finally, James Cropper (CRPR), the speciality paper firm which provides the material for Remembrance Day poppies, has just doubled half-year adjusted pre-tax profit. New products, cost-cutting and capital investment underpin bullish growth forecasts, says Westhouse. Average annual forecast EPS growth of 28% over the next three years appears not to be reflected in a forward earnings multiple of 12, dropping to just 9.3 in 2015.

This article is for information and discussion purposes only and does not form a recommendation to invest or otherwise. The value of an investment may fall. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

[hydrus] 06/5/2016 20:23

Yes a small mention thanks for the heads up I had s look this morning. I'm fine with the relatively low coverage at the moment. Nice quiet bulletin board and limited media coverage enables the company to get on and build what I expect will become a significant business in the next 3/4 years.

[pet lover] 06/5/2016 19:18

Back again. This mornings paper. As predicted Premier Veterinary Group yesterday revealed plans to expand into the US. Shares clawed up10.1% or 12.3P to 1.43P as the firm announced it would begin rolling at its healthcare programme in Georgia and North Carolina. There are around 70m pet dogs and 74m pet cats in the US and the largest competitor in the country is reported to have around 1m pets signed up to its services.

[pet lover] 06/5/2016 07:08

Can't hang around just been told PVG are in D Mail. I will pick up a copy on the way to the office.

[pet lover] 05/5/2016 18:09

Another day done and dusted😖. It is now looking far more likely that PVG can double the number of pet plans sold over the course of this financial year from 80,000 to 160,000. Denmark and the USA will have up to 4 months of sales to chip in which was not the case this time last month. Last year PVG did 40,000 to 80,000. The year end is 30/09/16. £20.00 a plan would bring in £3.2M next year plus £1.25M from the buying group. £4.45M excludes any part of the value of any new plans sold in 2016 // 2017. The numbers then start to get very serious in 17 months time if by then plan numbers have doubled again to 360,000. In which case over £8M of revenue would be delivered the following year without any growth what so ever in 2017 // 2018. Growth in that year could add another £2M to revenues.PVG appears to be delivering from the word go.The vets were sold for a very handy profit and now the past talked about global expansion is being reported through regular market updates. The hound and myself have seen this unfolding for months about time the companies broker pulled his finger out and put some numbers in the market for 2016/17 and 2017/18.☹ʊ39;☹️

[pet lover] 05/5/2016 17:15

Premier Veterinary Launches "Controlled Expansion" Into Huge US Market

Thu, 5th May 2016 08:47
LONDON (Alliance News) - Premier Veterinary Group PLC shares rose on Thursday as it officially launched its expansion into the US after appointing two regional sales managers to help springboard the company's plan to capture a potentially huge market in the country.


Premier Veterinary shares were up 8.9% to 131.50 pence per share on Thursday morning.

The company restructured the business late last year by moving away from physically operating veterinary clinics to focus on its subsidiary, Premier Vet Alliance Ltd, which provides services to third-party practices.

Premier Vet Alliance provides services to veterinary clinics, including the administration of a preventative healthcare program for pets branded "Pet Care Plan", and the operation of a buying group which offers enhanced discounts to member practices.

Pet Care Plan was launched back in 2011 and has proven successful enough for the company to make it the company's main focus and long-term value driver.

The amount of plans the company has under the Pet Care Plan has been steadily rising as the company deployed and expanded into other countries such as Denmark, Ireland and the Netherlands. But now Premier Veterinary has its eyes on the potentially huge US market.

Premier Veterinary said the available market for preventative healthcare programmes for pets across the US is estimated at around 70.0 million dogs and 74.0 million cats, citing numbers from the US Pet Ownership & Demographics Sourcebook 2012.

Premier Veterinary said the largest operator within the market, and therefore its biggest competitor, has around 1.0 million pets under such programmes.

The "controlled expansion" into the US has been launched after the company appointed two regional sales directors to work out of Atlanta, Georgia and Charlotte, North Carolina, to work under Premier Vet Alliance. Two training staff also have been appointed.

Craig Fraser joins the company from DVM Resources/Animal Healthcare International whilst Jennifer Scarberry has joined from her role at Antech Diagnostics. Both of them were regional sales managers prior to joining Premier Veterinary.

"Both executives have significant experience in veterinary product sales and following a recently completed training and induction period, they have already secured seven new hospital contracts for Pet Care Plan in Georgia, Mississippi, North Carolina and South Carolina," said the company.

[hibberts] 05/5/2016 14:35

Just had another top up,like the look of the move into the USA.

[pet lover] 05/5/2016 12:28

Quick lunchtime post more this evening after the hound has been fed and walked.
UK Ireland Denmark The Netherlands and now the new world America.
PVG is building up a head of steam profits should follow.
Recurring profits.
Starting to get exciting.